ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Oral Abstract Session

Glomerular Diseases: Charting New Territory

October 23, 2020 | 05:00 PM - 07:00 PM

Location: Simulive

Session Description

Oral Abstract Session

Learning Pathway(s)

  • Glomerular Diseases

Moderators

  • Mark Alan Little, MBChB, PhD
  • Ambra Pozzi, PhD, DrPH

Presentations

  • Development of Alport-Syndrome-on-a-Chip to Study the Glomerular Filtration Barrier Pathophysiology
    05:00 PM - 07:00 PM
    Laura Perin, PhD
  • Development of a Personalized Medicine Platform for Nonsense Readthrough Therapy in Alport Syndrome
    05:00 PM - 07:00 PM
    Kohei Omachi, PhD 
  • A ROBO2 Fusion Protein (PF-06730512) Traps SLIT Ligands and Therapeutically Ameliorates Podocyte Injury
    05:00 PM - 07:00 PM
    Stephen Berasi, PhD 
  • Semaphorin 3B-Associated Membranous Nephropathy
    05:00 PM - 07:00 PM
    Sanjeev Sethi, MD, PhD 
  • High Temperature Recombinant Protein A1 (HTRA1): A Novel Antigen in Membranous Nephropathy
    05:00 PM - 07:00 PM
    Laith Al-Rabadi, MD 
  • Protocadherin 7-Associated Membranous Nephropathy
    05:00 PM - 07:00 PM
    Sanjeev Sethi, MD, PhD 
  • Nefecon<sup>®</sup> (Budesonide) Selectively Reduces Circulating Levels of BAFF (BLyS) and Soluble BCMA and TACI in IgA Nephropathy
    05:00 PM - 07:00 PM
    Karen Molyneux, PhD 
  • NCAM1 Is an Autoantigen in Membranous Lupus Nephritis
    05:00 PM - 07:00 PM
    Tiffany Caza, MD, PhD 
  • KZR-616, A Selective Inhibitor of the Immunoproteasome: Preclinical and Clinical Mechanism of Action Studies in Lupus Nephritis
    05:00 PM - 07:00 PM
    Tony Muchamuel, MS
  • Alpha1-Antitrypsin Diminishes Neutrophil Activation by PR3-ANCA and Endothelial Injury by Neutrophil Serine Proteases
    05:00 PM - 07:00 PM
    Ralph Kettritz, MD, FASN